GTX-104 IV nimodipine shows improved outcomes in aSAH
A novel IV nimodipine (GTX-104) is described as delivering improved clinical outcomes and resource utilization versus oral nimodipine in aneurysmal subarachnoid hemorrhage (aSAH), with a stated strong safety profile.